Robert Campbell, PhD
Professor of Pharmaceutical Sciences
School
School of Pharmacy
Department
Pharmaceutical Sciences
Office Location
19 Foster 513
Worcester
Office Phone Office Phone: 508.373.5740
About
Education
- BS/BA Biology/Chemistry, Niagara University, Niagara University, NY
- MS Natural Sciences/ Biophysics Research, SUNY Buffalo-Roswell Park Cancer Institute, Buffalo, NY
- PhD, Molecular and Cellular Biophysics/ Pharmaceutics, SUNY Buffalo, NY
Featured Affiliations
American Association for Pharmaceutical Scientists
LinkAmerican Association for Cancer Research
LinkAmerican Cancer Society
LinkEducation
- BS/BA Biology/Chemistry, Niagara University, Niagara University, NY
- MS Natural Sciences/ Biophysics Research, SUNY Buffalo-Roswell Park Cancer Institute, Buffalo, NY
- PhD, Molecular and Cellular Biophysics/ Pharmaceutics, SUNY Buffalo, NY
Publications
- Kuesters, G. and Campbell, R. B. The conjugation of bevacizumab to cationic liposomes enhances their tumor targeting potential. Nanomedicine, 5(2):181-92 2010.
- Campbell, R. B., Ying, B., Kuesters, G. M., and Hemphill, R. Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics. Journal of Pharmaceutical Sciences, 98: 411-429, 2009.
- Dandamudi, S., Patil, V., Fowle, W., Khaw, B. A., and Campbell, R. B. External magnet enhances antitumor activity and suppresses melanoma metastasis. Cancer Science, 100: 1537-1543, 2009.
- Kalra, A. and Campbell, R. B. Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumors. European Journal of Cancer, 45: 164-173, 2009.
- Dabbas, S., Kaushik, R. R., Dandamudi, S., Kuesters, G. M., and Campbell, R. B. Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells. Endothelium, 15: 189-201, 2008.
- Campbell, R. B. Battling tumors with magnetic nanotherapeutics and hyperthermia: Turning up the heat. Nanomedicine, 2, 2007
- Campbell, R. B. Mucin Impedes Cytotoxic Activity of 5-FU Against Growth of Human Pancreatic Cancer Carcinoma Cells: Overcoming Cellular Barriers for Therapeutic Gain. 8;97(7):910-8, 2007.
- Dandamudi, S. and Campbell, R. B. The drug loading, cytotoxicity and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials, 28: 4673-4683, 2007.
- Dandamudi, S. and Campbell, R.B. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature. Biochim Biophys Acta. 1768(3):427-38, 2007.
- Kalra, A. V. and Campbell, R. B. Development of 5-FU and doxorubicin-loaded cationic liposomes against human pancreatic cancer: Implications for tumor vascular targeting. Pharm Res, 23: 2809-2817, 2006.